|Articles|February 1, 2005
Topping tamoxifen as 1st-line Rx for postmenopausal breast Ca
Aromatase inhibitors should replace tamoxifen as the first choice for preventing recurrence of breast cancer in postmenopausal women with localized hormone receptor-positive disease, according to this large-scale study.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Minipad-based HPV testing shows promise for cervical cancer screening
2
Kevin Ault, MD, on vaccines & autism, local government, HPV vaccine advocacy
3
Study data highlight trade-offs of testing for pregnancy too soon
4
Fionnuala McAuliffe, MD, highlights importance of timely breastfeeding discussions with patients
5





